Diabetic foot is a major public health issue, driven by diabetes complications (neuropathy, peripheral vascular disease, foot deformity, and abnormal leucocyte function), which may lead to leg amputation, thus resulting in severe disability, reduced quality of life, and high health costs. The prevention of diabetes complications and the early detection and proper management of diabetic foot wounds are the milestones to avoid major amputations. Unfortunately, in many areas, the prevention of diabetic foot lesions is inadequate and wounds may proceed toward infection and chronicity, with limb- and life-threatening results. Using the Delphi method, we conducted a survey on diabetic foot among Italian experts, selected across different Italian clinical centers. This method was used to achieve a consensus on current opinion and clinical leanings on the diagnosis and management of diabetic foot ulcers. Specifically, the aim of the survey was to evaluate the current management of the diabetic foot syndrome; highlight the differences in the approach among a group of experts; evaluate the role of wound bed preparation and antisepsis; and discuss any areas of disagreement in which evidences are sparse and the clinical judgment plays a crucial role in the decision-making process.
ChanJCMalikVJiaW, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-2140.
2.
IbrahimA.IDF clinical practice recommendation on the diabetic foot: a guide for healthcare professionals. Diabetes Res Clin Pract. 2017;127:285-287.
3.
ApelqvistJ. The diabetic foot syndrome today: a pandemic uprise. In: PiaggesiAApelqvistJ, eds. The Diabetic Foot Syndrome. Front Diabetes. Basel, Switzerland: Karger; 2018:1-18.
4.
ArmstrongDGBoultonAJMBusSA.Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:2367-2375.
5.
JupiterDCThorudJCBuckleyCJShibuyaN.The impact of foot ulceration and amputation on mortality in diabetic patients. I: from ulceration to death, a systematic review. Int Wound J. 2016;13:892-903.
6.
KerrMRaymanGJeffcoateWJ.Cost of diabetic foot disease to the National Health Service in England. Diabet Med. 2014;31:1498-1504.
7.
LazzariniPAPacellaREArmstrongDGvan NettenJJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability [published online May 23, 2018]. Diabet Med. doi:10.1111/dme.13680.
8.
BoultonAJM. The diabetic foot: epidemiology, risk factors and the status of care. Diabetes Voice. 2005;50(suppl 1):5-7.
9.
BoultonAJM. The diabetic foot: a global view. Diabetes Metab Res Rev. 2000;16(suppl 1):S2-S5.
10.
DiamondIRGrantRCFeldmanBM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401-409.
11.
HassonFKeeneySMcKennaH.Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32:1008-1015.
12.
NairRAggarwalRKhannaD.Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum. 2011;41:95-105.
13.
RaymanGVasPDhatariyaKDriverVHartemannALondahlM. IWGDF guideline on interventions to enhance healing of foot ulcers in persons with diabetes. Diabetes Metab Res Rev. In press.
14.
LipskyBABerendtARCorniaPB, et al; Infectious Diseases Society of America. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132-e173.
15.
GershaterMALondahlMNybergP, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52:398-407.
16.
SchaperNCApelqvistJBakkerK.Reducing lower leg amputations in diabetes: a challenge for patients, healthcare providers and the healthcare system. Diabetologia. 2012;55:1869-1872.
17.
PendseySP.Epidemiological aspects of the diabetic foot. Int J Diab Dev Countries. 1994;2:37-38.
18.
KimCHMoonJSChungSM, et al. The changes of trends in the diagnosis and treatment of diabetic foot ulcer over a 10-year period: single center study. Diabetes Metab J. 2018;42:308-319.
19.
AnichiniRPolicardoLLombardoFL, et al. Hospitalization for Charcot neuroarthopathy: a population study in Italy. Diabetes Res ClinPract. 2017;129:25-31.
20.
EdmondsMFosterA.The use of antibiotics in the diabetic foot. Am J Surg. 2004;187(5A):25S-28S.
21.
GardnerSEFrantzRA.Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs. 2008;10:44-53.
22.
D’AtanasioNDe JoannonAC, et al. Role of a new acidoxidant solution in the control of wounds microenvironment. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2015;174:431-430.
23.
GreenerBHughesAABannisterNPDouglassJ.Proteases and pH in chronic wounds. J Wound Care. 2005;14:59-61.
24.
FejfarováVTibenskáHNiklováJ, et al. Benefits of acidifying agents in local therapy of diabetic foot ulcers infected by Pseudomonas sp: a pilot study. Int J Low Extrem Wounds. 2019;18:262-268.
25.
CharbonneauNLCarlsonEJTufaS, et al. In vivo studies of mutant fibrillin-1 microfibrils. J Biol Chem. 2010;285:24943-24955.
26.
PercivalSLMcCartySHuntJAWoodsEJ.The effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound Repair Regen. 2014;22:174-186.
27.
EnerothMApelqvistJStenstromA.Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int. 1997;18:716-722.
28.
EnerothMLarssonJApelqvistJ.Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications. 1999;13:254-263.
29.
ArmstrongDGLaveryLAHarklessLB.Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21:855-859.
30.
JonesV.Debridement of diabetic foot lesions. Diabet Foot. 1998;1:88-94.
31.
RauwerdaJA.Foot debridement: anatomic knowledge is mandatory. Diabetes Metab Res Rev. 2000;16(suppl 1):S23-S26.
32.
SmithJ.Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2002;(4):CD003556.
33.
DumvilleJCLipskyBAHoeyCCrucianiMFisconMXiaJ.Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017;(6):CD011038.
34.
GameFLAttingerCHartemannA, et al; International Working Group on the Diabetic Foot. IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2016;32(suppl 1):75-83.
35.
ApelqvistJLarssonJAgardhCD.Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233:485-491.
36.
JoshiNCaputoGMWeitekampMRKarchmerAW.Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-1912.
37.
LombardoFLMagginiMDe BellisASeghieriGAnichiniR.Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010. PLoS One. 2014;9:e86405.
38.
LarssonJApelqvistJ.Towards less amputations in diabetic patients. Incidence, causes, cost, treatment, and prevention—a review. Acta Orthop Scand. 1995;66:181-192.
39.
BakkerKApelqvistJSchaperNC; International Working Group on Diabetic Foot Editorial Board. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28(suppl 1):225-231.
40.
VasPRJEdmondsMKavarthapuV, et al. The diabetic foot attack: “Tis too late to retreat!”Int J Low Extrem Wounds. 2018;17:7-13.
41.
JhambSVangavetiVNMalabuUH.Genetic and molecular basis of diabetic foot ulcers: clinical review. J Tissue Viability. 2016;25:229-236.
42.
Pop-BusuiRAngLHolmesCGallagherKFeldmanEL.Inflammation as a therapeutic target for diabetic neuropathies. Curr Diab Rep. 2016;16:29.
43.
EleftheriadouITentolourisNArgianaVJudeEBoultonAJ.Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70:1785-1797.
44.
FrykbergRGBanksJ.Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle). 2015;4:560-582.
45.
KinmondKMcGeePGoughSAshfordR.“Loss of self”: a psychosocial study of the quality of life of adults with diabetic foot ulceration. J Tissue Viability. 2003;13:6-8, 10, 12.
46.
KyawBMJarbrinkKMartinengoLCarJHardingKSchmidtchenA.Need for improved definition of “chronic wounds” in clinical studies. Acta Derm Venereol. 2018;98:157-158.
47.
PosnettJFranksPJ.The burden of chronic wounds in the UK. Nurs Times. 2008;104:44-45.
48.
SenCKGordilloGMRoyS, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763-771.
49.
WalkerNRodgersABirchallNNortonRMacMahonS.Leg ulcers in New Zealand: age at onset, recurrence and provision of care in an urban population. N Z Med J. 2002;115:286-289.
50.
ApelqvistJLarssonJ.What is the most effective way to reduce incidence of amputation in the diabetic foot?Diabetes Metab Res Rev. 2000;16(suppl 1):S75-S83.
51.
BakkerKApelqvistJLipskyBAVan NettenJJ; International Working Group on the Diabetic Foot. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016;32(suppl 1):2-6.
52.
CarinciFUccioliLBenedettiMMKlazingaNS. An in-depth assessment of diabetes-related lower extremity amputation rates 2000-2013 delivered by twenty-one countries for the data collection 2015 of the Organization for Economic Cooperation and Development (OECD) [published online October 11, 2019]. Acta Diabetol. doi:10.1007/s00592-019-01423-5
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
